Drug Approval | June 26, 2026
Merck wins EU nod for KEYTRUDA-Padcev regimen in muscle-invasive bladder cancer
The approval is based on results from the pivotal Phase 3 KEYNOTE-905 trial
The approval is based on results from the pivotal Phase 3 KEYNOTE-905 trial
Karkinos’ model aims to close both gaps by combining World Health Organization-recommended HPV DNA testing with a digitally enabled continuum of care
Centessa is a clinical-stage biotech focused on developing orexin receptor 2 agonists
Health ministry notifies amendments to the Drugs Rules, 1945 to expand the ambit of Schedule H2 and bring additional categories of drugs under the QR Code-based track and trace framework
Objective Structured Clinical Examination (OSCE) are widely used to evaluate medical students' practical competencies, communication, professionalism, and clinical decision-making
The Trivitron Healthcare CMD and FICCI Tamil Nadu Chairman was honoured for advancing indigenous innovation and strengthening India's healthcare ecosystem
Awalgaonkar's cross-industry expertise positions him to further strengthen the company's procurement capabilities and support its long-term growth strategy
Backed by Phase 3 trial showing 24% lower risk of progression
The offer is being made through Harmony Row Acquisition Co., a wholly owned GSK subsidiary, and targets all outstanding Class A and Class B shares of Nuvalent
The company emphasized that its mRNA system is built on three pillars—mRNA science, delivery science, and manufacturing processes
Subscribe To Our Newsletter & Stay Updated
